Office of Research & Development |
  |
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I01BX003741-01A2 |
| Title: | Optimization of therapeutic mAbs to carbapenem resistant Klebsiella clone ST258 |
| Principal Investigator: | Bettina Fries |
| Location: | Northport, NY |
| Congressional District Code: | 3 |
| Research Service: | Biomedical Laboratory R&D |
| Project Period: | January 2019 - December 2022 |
| FY 2021 Funding Amount: | $156,780 |
| Total Award Amount (all years): |
$778,940 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Carbapenem resistant Klebsiella pneumoniae (CR-Kp) bacteria are the most common gram-negative multidrug-resistant bacteria in US hospitals. CR-Kp cause predominantly pneumonia, sepsis and urinary tract infections and, in military personnel, complicated invasive wound infections as well. Most patients acquire this pathogen in health care associated settings. Soldiers are at risk because they commonly have prolonged stays in hospitals and rehabilitation centers when they recover from injuries they... |